Barclays’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-976
| Closed | -$12K | – | 3302 |
|
|
2021
Q3 | $12K | Sell |
976
-247
| -20% | -$3.04K | ﹤0.01% | 3722 |
|
|
2021
Q2 | $19K | Sell |
1,223
-4,304
| -78% | -$66.9K | ﹤0.01% | 3731 |
|
|
2021
Q1 | $133K | Buy |
5,527
+3,393
| +159% | +$81.6K | ﹤0.01% | 3280 |
|
|
2020
Q4 | $63K | Sell |
2,134
-843
| -28% | -$24.9K | ﹤0.01% | 3107 |
|
|
2020
Q3 | $46K | Buy |
2,977
+14
| +0.5% | +$216 | ﹤0.01% | 3323 |
|
|
2020
Q2 | $73K | Buy |
2,963
+1,298
| +78% | +$32K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $34K | Sell |
1,665
-3,378
| -67% | -$69K | ﹤0.01% | 3234 |
|
|
2019
Q4 | $156K | Buy |
5,043
+2,557
| +103% | +$79.1K | ﹤0.01% | 3287 |
|
|
2019
Q3 | $83K | Sell |
2,486
-765
| -24% | -$25.5K | ﹤0.01% | 3489 |
|
|
2019
Q2 | $104K | Buy |
3,251
+1,841
| +131% | +$58.9K | ﹤0.01% | 3569 |
|
|
2019
Q1 | $40K | Buy |
+1,410
| New | +$40K | ﹤0.01% | 3733 |
|
|
2018
Q4 | – | Sell |
-2,360
| Closed | -$110K | – | 4110 |
|
|
2018
Q3 | $110K | Buy |
2,360
+1,983
| +526% | +$92.4K | ﹤0.01% | 3358 |
|
|
2018
Q2 | $31K | Sell |
377
-4,243
| -92% | -$349K | ﹤0.01% | 3475 |
|
|
2018
Q1 | $193K | Sell |
4,620
-2,052
| -31% | -$85.7K | ﹤0.01% | 2855 |
|
|
2017
Q4 | $217K | Buy |
+6,672
| New | +$217K | ﹤0.01% | 2600 |
|